The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Homocysteine Levels and the Risk of Osteoporotic Fracture
Open accessAbstract
BACKGROUND: Very high plasma homocysteine levels are characteristic of homocystinuria, a rare autosomal recessive disease accompanied by the early onset of generalized osteoporosis. We therefore hypothesized that mildly elevated homocysteine levels might be related to age-related osteoporotic fractures. METHODS: We studied the association between circulating homocysteine levels and the risk of incident osteoporotic fracture in 2406 subjects, 55 years of age or older, who participated in two separate prospective, population-based studies. In the Rotterdam Study, there were two independent cohorts: 562 subjects in cohort 1, with a mean follow-up period of 8.1 years; and 553 subjects in cohort 2, with a mean follow-up period of 5.7 years. In the Longitudinal Aging Study Amsterdam, there was a single cohort of 1291 subjects, with a mean follow-up period of 2.7 years. Multivariate Cox proportional-hazards regression models were used for analysis of the risk of fracture, with adjustment for age, sex, body-mass index, and other characteristics that may be associated with the risk of fracture or with increased homocysteine levels. RESULTS: During 11,253 person-years of follow-up, osteoporotic fractures occurred in 191 subjects. The overall multivariable-adjusted relative risk of fracture was 1.4 (95 percent confidence interval, 1.2 to 1.6) for each increase of 1 SD in the natural-log-transformed homocysteine level. The risk was similar in all three cohorts studied, and it was also similar in men and women. A homocysteine level in the highest age-specific quartile was associated with an increase by a factor of 1.9 in the risk of fracture (95 percent confidence interval, 1.4 to 2.6). The associations between homocysteine levels and the risk of fracture appeared to be independent of bone mineral density and other potential risk factors for fracture. CONCLUSIONS: An increased homocysteine level appears to be a strong and independent risk factor for osteoporotic fractures in older men and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Mortality after all major types of osteoporotic fracture in men and women: an observational study
Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N., & Eisman, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09075-8 · Cited by 1,926
Heritable Disorders of Connective Tissue
(1960) · Postgraduate Medical Journal · doi:10.1136/pgmj.36.415.346 · Cited by 1,527
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Self-citationde Leeuw, F.-E. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.9 · Cited by 1,291
Ray, N. F., Chan, J. K., Thamer, M., & Melton, L. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.24 · Cited by 1,281
The natural history of homocystinuria due to cystathionine beta-synthase deficiency.
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B. M., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., & Cerone, R. (1985) · PubMed · Cited by 1,256
Cited by
Luminescent Chemodosimeters for Bioimaging
Yang, Y., Zhao, Q., Feng, W., & Li, F. (2013) · Chemical Reviews · doi:10.1021/cr2004103 · Cited by 2,236
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
The Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Self-citationCholine: an essential nutrient for public health
Zeisel, S. H., & da Costa, K.-A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00246.x · Cited by 1,062
Saito, M., & Marumo, K. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 906
Detection of Homocysteine and Cysteine
Wang, W., Rusin, O., Xu, X., Kim, K. K., Escobedo, J. O., Fakayode, S. O., Fletcher, K. A., Lowry, M., Schowalter, C. M., Lawrence, C. M., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja054962n · Cited by 593
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs
Cirino, G., Szabo, C., & Papapetropoulos, A. (2023) · Physiological Reviews · doi:10.1152/physrev.00028.2021 · Cited by 553
Relationship Between Osteoporosis and Cardiovascular Disease in Postmenopausal Women
Tankó, L. B., Christiansen, C., Cox, D. A., Geiger, M. J., McNabb, M. A., & Cummings, S. R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050711 · Cited by 545
Vitamin B12 in Health and Disease
O’Leary, F., & Samman, S. (2010) · Nutrients · doi:10.3390/nu2030299 · Cited by 524
“Cohort [87] Elderly, fracture risk For 1 SD in tHcy fracture RR =1.”
BackgroundRefsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Cohort Profile: The Longitudinal Aging Study Amsterdam
Huisman, M., Poppelaars, J., van der Horst, M., Beekman, A. T., Brug, J., van Tilburg, T. G., & Deeg, D. J. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq219 · Cited by 467
Jadoul, M., Albert, J. M., Akiba, T., Akizawa, T., Arab, L., Bragg-Gresham, J. L., Mason, N., Prutz, K.-G., Young, E. W., & Pisoni, R. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001754 · Cited by 466
Pfeiffer, C. M., Caudill, S. P., Gunter, E. W., Osterloh, J., & Sampson, E. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.2.442 · Cited by 436
Ralston, S. H., & Uitterlinden, A. G. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0044 · Cited by 376
Self-citationChen, X., Jhee, K.-H., & Kruger, W. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400481200 · Cited by 330
Folic acid: a public-health challenge
Eichholzer, M., Tönz, O., & Zimmermann, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68582-6 · Cited by 325
The Treatment of Hyperhomocysteinemia
Maron, B. A., & Loscalzo, J. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123308 · Cited by 313
Impact of nutrition on muscle mass, strength, and performance in older adults
for the IOF CSA Nutrition Working Group, Mithal, A., Bonjour, J.-P., Boonen, S., Burckhardt, P., Degens, H., El Hajj Fuleihan, G., Josse, R., Lips, P., Morales Torres, J., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2236-y · Cited by 301
Self-citationA thiol-specific fluorescent probe and its application for bioimaging
Chen, X., Ko, S.-K., Kim, M. J., Shin, I., & Yoon, J. (2010) · Chemical Communications · doi:10.1039/b925453f · Cited by 289
The Rotterdam Study: 2012 objectives and design update
Hofman, A., van Duijn, C. M., Franco, O. H., Ikram, M. A., Janssen, H. L. A., Klaver, C. C. W., Kuipers, E. J., Nijsten, T. E. C., Stricker, B. H. C., Tiemeier, H., et al. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9610-5 · Cited by 289
Self-citationNgamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.113 · Cited by 281
A fluorescein-based probe with high selectivity to cysteine over homocysteine and glutathione
Wang, H., Zhou, G., Gai, H., & Chen, X. (2012) · Chemical Communications · doi:10.1039/c2cc33932c · Cited by 271
Liu, Y., Yang, R., Liu, X., Zhou, Y., Qu, C., Kikuiri, T., Wang, S., Zandi, E., Du, J., Ambudkar, I. S., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.03.005 · Cited by 269
Trajanoska, K., Morris, J. A., Oei, L., Zheng, H.-F., Evans, D. M., Kiel, D. P., Ohlsson, C., Richards, J. B., & Rivadeneira, F. (2018) · BMJ · doi:10.1136/bmj.k3225 · Cited by 265
Two-photon luminescent metal complexes for bioimaging and cancer phototherapy
Chen, Y., Guan, R., Zhang, C., Huang, J., Ji, L., & Chao, H. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.09.010 · Cited by 259
The Rotterdam Study: 2010 objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Janssen, H. L. A., Krestin, G. P., Kuipers, E. J., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., et al. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9386-z · Cited by 244
“Among the biomarker analyses our study documenting the relationship between homocysteine and osteoporosis was novel [185] and has since been widely replicated.”
BackgroundSelf-citationvan Meurs, J. B., Pare, G., Schwartz, S. M., Hazra, A., Tanaka, T., Vermeulen, S. H., Cotlarciuc, I., Yuan, X., Mälarstig, A., Bandinelli, S., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.044545 · Cited by 198
Self-citationHerrmann, M., Peter Schmidt, J., Umanskaya, N., Wagner, A., Taban-Shomal, O., Widmann, T., Colaianni, G., Wildemann, B., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.362 · Cited by 124
Osteoporosis after stroke: a review of the causes and potential treatments
Carda, S., Cisari, C., Invernizzi, M., & Bevilacqua, M. (2009) · Cerebrovascular Diseases · doi:10.1159/000226578 · Cited by 104
RetractedMillard, H. R., Musani, S. K., Dibaba, D. T., Talegawkar, S. A., Taylor, H. A., Tucker, K. L., & Bidulescu, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1296-8 · Cited by 101
van Wijngaarden, J. P., Swart, K. M., Enneman, A. W., Dhonukshe-Rutten, R. A., van Dijk, S. C., Ham, A. C., Brouwer-Brolsma, E. M., van der Zwaluw, N. L., Sohl, E., van Meurs, J. B., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090043 · Cited by 91
Self-citationMa, C.-H., Chiua, Wu, C.-H., Jou, I.-M., Tu, Y.-K., Hung, C.-H., Hsieh, P.-L., & Tsai, K.-L. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.010 · Cited by 86
“In fact, various studies have revealed that the abnormality of Hcy was associated with several orthopedic disorders, such as osteoporosis [23] and fractures [24].”
BackgroundBehera, J., Kelly, K. E., Voor, M. J., Metreveli, N., Tyagi, S. C., & Tyagi, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-33149-9 · Cited by 59
Green, T. J., McMahon, J. A., Skeaff, C. M., Williams, S. M., & Whiting, S. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.460 · Cited by 56
“Most notably, results from 2 large prospective studies indicate that elevated homocysteine concentrations are an independent risk factor for osteoporotic fractures in older persons (6, 7).”
BackgroundHerrmann, M., Umanskaya, N., Traber, L., Schmidt-Gayk, H., Menke, W., Lanzer, G., Lenhart, M., Peter Schmidt, J., & Herrmann, W. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.352 · Cited by 55
“Observational studies showed a 2–4-fold increase of fracture risk in subjects with high circulating HCY concentrations (7, 8, 10).”
BackgroundShen, G. S., Yang, Q., Jian, J. L., Zhao, G. Y., Liu, L. L., Wang, X., Zhang, W., Huang, X., & Xu, Y. J. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9845-8 · Cited by 51
Randomized Clinical Trial of Homocysteine Level–Lowering Therapy and Fractures
Sawka, A. M., Ray, J. G., Yi, Q., Josse, R. G., & Lonn, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2136 · Cited by 47
Gommans, J., Yi, Q., Eikelboom, J. W., Hankey, G. J., Chen, C., & Rodgers, H. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-88 · Cited by 42
Association of hyperhomocysteinemia with osteoporosis: a systematic review
Salari, P., Larijani, B., & Abdollahi, M. (2008) · Therapy · doi:10.2217/14750708.5.2.215 · Cited by 27
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · JAMA · doi:10.1001/jama.293.9.1082 · Cited by 2
“In accordance with these findings, 2 previous studies failed to find a relationship between homocysteine concentrations and BMD.(21,36) There is only limited evidence for the direct effect of homocysteine on bone, including its density.”
BackgroundResultInfluentialRetracted
Metadata
- Authors
- van Meurs, J. B. J., Dhonukshe-Rutten, R. A. M., Pluijm, S. M. F., van der Klift, M., de Jonge, R., Lindemans, J., de Groot, L. C. P. G. M., Hofman, A., Witteman, J. C. M., van Leeuwen, J. P. T. M., Breteler, M. M. B., Lips, P., Pols, H. A. P., & Uitterlinden, A. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-13
- Volume
- 350
- Issue
- 20
- Pages
- 2033-2041
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2099007490
- Cited by
- 740
- References
- 29
- FWCI
- 55.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.